- Home
- JAKK vs TVRD Comparison
JAKK vs TVRD Comparison
Compare JAKK & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- TVRD
- Stock Information
- Founded
- JAKK 1995
- TVRD 2017
- Country
- JAKK United States
- TVRD United States
- Employees
- JAKK N/A
- TVRD N/A
- Industry
- JAKK Recreational Games/Products/Toys
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- TVRD Health Care
- Exchange
- JAKK Nasdaq
- TVRD Nasdaq
- Market Cap
- JAKK 206.8M
- TVRD 246.5M
- IPO Year
- JAKK 1996
- TVRD N/A
- Fundamental
- Price
- JAKK $18.42
- TVRD $4.79
- Analyst Decision
- JAKK Strong Buy
- TVRD Buy
- Analyst Count
- JAKK 4
- TVRD 7
- Target Price
- JAKK $37.75
- TVRD $51.67
- AVG Volume (30 Days)
- JAKK 90.4K
- TVRD 681.5K
- Earning Date
- JAKK 10-30-2025
- TVRD 11-21-2025
- Dividend Yield
- JAKK 5.35%
- TVRD N/A
- EPS Growth
- JAKK 25.15
- TVRD N/A
- EPS
- JAKK 3.34
- TVRD N/A
- Revenue
- JAKK $684,694,000.00
- TVRD N/A
- Revenue This Year
- JAKK N/A
- TVRD N/A
- Revenue Next Year
- JAKK $4.06
- TVRD N/A
- P/E Ratio
- JAKK $5.59
- TVRD N/A
- Revenue Growth
- JAKK 1.31
- TVRD N/A
- 52 Week Low
- JAKK $16.24
- TVRD $4.48
- 52 Week High
- JAKK $35.79
- TVRD $43.65
- Technical
- Relative Strength Index (RSI)
- JAKK 45.98
- TVRD 19.81
- Support Level
- JAKK $18.86
- TVRD $4.48
- Resistance Level
- JAKK $19.75
- TVRD $7.23
- Average True Range (ATR)
- JAKK 0.68
- TVRD 0.72
- MACD
- JAKK -0.09
- TVRD -0.95
- Stochastic Oscillator
- JAKK 36.85
- TVRD 0.69
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.